Cargando…
Clinical manifestations of new versus recrudescent malaria infections following anti-malarial drug treatment
BACKGROUND: Distinguishing new from recrudescent infections in post-treatment episodes of malaria is standard in anti-malarial drug efficacy trials. New infections are not considered malaria treatment failures and as a result, the prevention of subsequent episodes of malaria infection is not reporte...
Autores principales: | Shaukat, Ayesha M, Gilliams, Elizabeth A, Kenefic, Leo J, Laurens, Matthew B, Dzinjalamala, Fraction K, Nyirenda, Osward M, Thesing, Phillip C, Jacob, Christopher G, Molyneux, Malcolm E, Taylor, Terrie E, Plowe, Christopher V, Laufer, Miriam K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489583/ https://www.ncbi.nlm.nih.gov/pubmed/22709627 http://dx.doi.org/10.1186/1475-2875-11-207 |
Ejemplares similares
-
A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria
por: Laufer, Miriam K., et al.
Publicado: (2012) -
Timing of Malaria Infection during Pregnancy Has Characteristic Maternal, Infant and Placental Outcomes
por: Kalilani-Phiri, Linda, et al.
Publicado: (2013) -
TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial
por: Laurens, Matthew B., et al.
Publicado: (2016) -
Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi
por: Nyangulu, Wongani, et al.
Publicado: (2023) -
The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development
por: Mandala, Wilson L., et al.
Publicado: (2021)